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SUMMARY 
Twenty five patients of endogenous depression fulfilling Feighner's criteria were selected for this 
study. It was found that the patients who improved with methylamphetamine responded to imipramine and 
those who did not improve with methylamphetamine improved with amitriptyline. 
For the past decade a large variety of 
drugs has been found to be effective in the 
treatment of Depression. Their precise 
indicators however, are not yet clearly 
known. 
There is therefore, a need for devising 
a method for the prediction of response to 
anti-depressant medication. There are 
different symptom complexes of depression 
which respond differently to different types 
of antidepressant medication currently avail-
able. Various clinical, bio-chemical and 
pharmacological predictors have been re-
ported with only a few studies of response 
prediction appearing in the literature 
(Murphy et al., 1978). 
A current approach to depression is 
that of the "two disease model of depression" 
(Davis, 1976). According to this hypothesis 
there are at least two types of depression 
referred to as type A and type B which are 
distinct from each other as determined by 
certain parameters (Davis, 1976, Mass, 
1975, 1978, Asberg et al., 1973). 
Type A 
(1) Low levels of MHPG 
(2) Positive response to impiramine 
(3) Brightening pf mood with ampheta-
mines 
Type B 
(1) Normal levels of MHPG 
(2) Positive response to amitriptyline 
(3) No change of mood with ampheta-
mines. 
There is a wide variation in the central 
nervous system stimulant action of ampheta-
mines (Lasagana et al., 1953, Tecce & Cole 
1974, Von Kamman & Murphy, 1978). 
If one intravenous administration of methyle-
amphetamine can predict response to anti-
depressants which otherwise require 3-6 
weeks trial it would be a great advantage 
over the present trial and error method. 
This study is an attempt to predict 
selective response to imipramine or ami-
triptyline on the basis of one intravenous 
injection of methyleamphetamine. 
MATERIAL AND METHODS 
This study was conducted on 25 patients 
treated at the Department of Psychiatry, 
R. N. T. Medical College & Associated 
Groups of Hospitals, Udaipur. They were 
suffering from endogenus depression ful-
filling Feighner's diagnostic criteria for use 
in Psychiatric research for Primary De-
pression (Feighner et al., 1972). Three 
patients who did not come for follow up 
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were dropped from the study. • All the 
patients had a score above twenty on 
Hamilton Depression Rating Scale. 
The drugs were divided into two 
groups. Group I comprised of a Placebo 
(10 cc of 10% injection G.N.S.) and In-
jection methylamphetamine 20 mg/1.0 ml 
in 9 cc of GNS. Group II comprised of 
imipramine and aniitriptyline tablets (25 
mg/tab.). 
Patients were rated initially on 
Hamilton Depression Rating Seal before 
treatment and Group I drugs were given 
slowly intervenously in a double blind 
manner. Patients were evaluated one hour 
after group I drug and 50% reduction in 
the partial score (4 items on Hamilton 
Depression Rating Scale of—depressed 
mood, work and interest retardation, agi-
tation)—was used as a measure to evaluate 
the response to drugs of Group I (Quadri 
etal., 1980). 
Group II drugs were not started 
(double blind) with gradul increase in dose 
starting from 100 mg to 225 mg. Patients 
were rated on Hamilton Depression Rating 
Scale at the end of 2nd and 4th week of 
starting the Group II drugs. 
RESULTS 
Table 1 shows the response to Group 
I drugs as evaluated on partial scores of 
HDRS one hour after the use. Chi-Square 
with Yate's correction was used for finding 
statistical significance. Table (1) shows 
improvement in 9 out of 12 patients who 
had been given methyleamphetamine which 
is highly significant (p<0.01). 
Table 3 shows that 3 pattents who did 
not improve with methylamphetamine 
improved with amitriptyline while out of 
9 patients who improved with methyle-
amphetamine 6 patients who received imi-
pramine improved whereas 3 patients who 
received amitriptyline did not improve. 
Table 2 shows the response to tricyclics 
at the end of 4th week. 7 patients who 
did not improve with the tricyclics were 
later given ECT. 
It can thus be seen that patients who 
improve with methyleamphetamine respond 
to imipramine whereas patients who do 
not improve with methyleamphetamine 
improve with amitriptyline. 
TABLE 1—Response to Group I drugs as eva-
luated on partial scores of HDRS 1 hour 
after the use. 
Inj. 
Inj. GNS Methyle- Total 
10% ampheta-
mine 
Improved .. 9 9 
Not-improved 10 3 13 
10 12 22 
X»=9.78, d.f. = l, p<0.01 
TABLE 2—Response to Group II drugs as eva-
luate ond HDRS at the end of 4th week. 
Imi- Amitri- Total 
pramine ptyline 
Improved 9 6 15 
Not-improved 3 4 7 
12 10 22 
X
2=0.08, d.f. = l, N-S. 
TABLE 3—Response to group I and group II 
drugs. 
Response to Me- Response Response 
thyleamphetamine to to Total 
Impiramine Amitri-
ptyline 
I NI I NI 
Improved 6 0 0 3 9 
Not-improved 0 0 3 0 3 
6 0 3 3 12 
NI=not improved, I = improved. 130  S. K. SHARMA et al. 
DISCUSSION 
We found a significant association 
between response to methyleamphetamine 
and selective prediction of response for 
amitriptyline and imipramine. Similar 
studies have been reported by Fawcett and 
Siomopoulos (1971), Von Kammer and 
Murphy (1978), Quadri et al. (1980) 
using oral d-amphetamine which required 
1-3 days for prediction of response to 
tricyclics. Our study has distinct advantages 
as we can not only predict the response just 
after an hour but also select the drug, 
IMIPRAMINE or AMITRIPTYLINE, 
which is likely to be effective. Our study 
also supports the two disease model of de-
pression (Davis, 1976). 
We agree that the number of patients 
in our study is small but similar limitations 
are present in the studies of Fawcett & 
Siomopoulos (1971), Von Kammer and 
Murphy (1978) and Quadri et al. (1980). 
Furthermore on extensive screening of lite-
rature we could not find any study using 
intra-venous methyl amphetamine as a pre-
dictor of response to tricyclic antidepressants. 
Though the distribution of the patients 
to the two antidepressant drugs was a 
blind one it has so happened that not a 
single case of no improvement to methyle-
amphetamine category was given imipra-
mine and all the three cases of this category 
(not improved to methyl amphetamine) 
Were given amitriptyline. 
We also agree that to come to a definite 
conclusion it is desirable that some patients 
of this category should be given imipramine 
and if they do not improve it can be defi-
nitely concluded that the responders to 
methyleamphetamine injection improve with 
imipramine and non-responders improve 
with amitriptyline. Further work is needed 
in this direction. 
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